Germany
Japan
United Kingdom
China
Recombinant Anti-CMKLR1 (Clone BZ194)
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Antibodies
View as table DownloadRecombinant Anti-Tim-4 (Clone 5G3)
| Applications | Bl, ELISA, FC, IF, IHC, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Tim-4 (Clone 5G3)
| Applications | Bl, ELISA, FC, IF, IHC, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-Tim-4 (Clone 3A1)
| Applications | Bl, ELISA, FC, IF, IHC, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Tim-4 (Clone 3A1)
| Applications | Bl, ELISA, FC, IF, IHC, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-CD25 (Clone PC-61.5.3)
| Applications | ELISA, FC, IF, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD25 (Clone PC-61.5.3)
| Applications | ELISA, FC, IF, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
| Modifications | This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD4 (Clone DB81)
| Applications | ELISA, FC, Neutralize |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD4 (Clone DB81)
| Applications | ELISA, FC, Neutralize |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD18 (Clone 1B4)
| Applications | ELISA, FC, IF, IP |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
Recombinant Anti-CD18 (Clone 1B4)
| Applications | ELISA, FC, IF, IP |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-RAGE (Clone 2A11)
| Applications | ELISA, FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-RAGE (Clone 2A11)
| Applications | ELISA, FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-TIGIT (Clone 1B4)
| Applications | Bl, ELISA, FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-TIGIT (Clone 1B4)
| Applications | Bl, ELISA, FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-IL-9 (Clone MH9A4)
| Applications | ELISA, FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-IL-9 (Clone MH9A4)
| Applications | ELISA, FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-IL-9 (Clone RM9A4)
| Applications | ELISA, FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-IL-9 (Clone RM9A4)
| Applications | ELISA, FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-CD155 (Clone 3F1)
| Applications | ELISA, FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD155 (Clone 3F1)
| Applications | ELISA, FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-PD-1 (Clone J43)
| Applications | ELISA, FC, IHC, IP, Neutralize |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-PD-1 (Clone J43)
| Applications | ELISA, FC, IHC, IP, Neutralize |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-VISTA (Clone 13F3)
| Applications | Bl, ELISA, FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-VISTA (Clone 13F3)
| Applications | Bl, ELISA, FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD1a (Clone CBT6)
| Applications | ELISA, FC, IHC, IP |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD1a (Clone CBT6)
| Applications | ELISA, FC, IHC, IP |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD74 (Clone LN-2)
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Recombinant Anti-CD74 (Clone LN-2)
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-C5aR (Clone S5/1)
| Applications | Bl, ELISA, FC, IP, WB |
| Reactivities | Ferret, Human, Rabbit, Cow |
| Conjugation | Unconjugated |
Recombinant Anti-C5aR (Clone S5/1)
| Applications | Bl, ELISA, FC, IP, WB |
| Reactivities | Ferret, Human, Rabbit, Cow |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CCR5 (Clone T21/8)
| Applications | ELISA, FC, IF, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CCR5 (Clone T21/8)
| Applications | ELISA, FC, IF, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CCR5 (phosphoserine 337) (Clone V14/2)
| Applications | ELISA, FC, IF, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CCR5 (phosphoserine 337) (Clone V14/2)
| Applications | ELISA, FC, IF, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
USD 523.00
2 Weeks
Recombinant Anti-EGFR (Clone 2F8 (Zalutumumab; HuMax-EGFR))
| Applications | ELISA, FC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
USD 523.00
2 Weeks
Recombinant Anti-EGFR (Clone 2F8 (Zalutumumab; HuMax-EGFR))
| Applications | ELISA, FC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-EpCAM (Clone KS1/4)
| Applications | ELISA, FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-EpCAM (Clone KS1/4)
| Applications | ELISA, FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-4-1BB (Clone 4B4-1-1)
| Applications | ELISA, FC, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-4-1BB (Clone 4B4-1-1)
| Applications | ELISA, FC, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-BRD4 (Clone RAB-C131)
| Applications | ChIP, ELISA, FC, IF |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Human Fab format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-WDR5 (Clone RAB-C223)
| Applications | ChIP, ELISA, FC, IF |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Human Fab format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-L3MBTL1 (Clone RAB-C213)
| Applications | ChIP, ELISA, FC, IF |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Human Fab format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-SETD7 (Clone RAB-C220)
| Applications | ChIP, ELISA, FC, IF |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Human Fab format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-FOXP4 (Clone RAB-S40)
| Applications | ELISA, FC, IF |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Human Fab format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-FOXP1 (Clone RAB-S37)
| Applications | ELISA, FC, IF |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Human Fab format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-FOXP2 (Clone RAB-S249)
| Applications | ELISA, FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Human Fab format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Mesothelin (Clone 11-25)
| Applications | ELISA, FC, IP |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Mesothelin (Clone 11-25)
| Applications | ELISA, FC, IP |
| Reactivities | Human |
| Conjugation | Unconjugated |
Active filters
Applications
- FC
Assay Types
- Indirect
Filter by
Category
Target Symbol
- CD4 (7)
- CD52 (6)
- IL2RA (6)
- EGFR (5)
- AOC3 (4)
- CCR5 (4)
- CCRL2 (4)
- IL9 (4)
- MUC1 (4)
- TIMD4 (4)
- TNFRSF8 (4)
- VEGFA (4)
- CD28 (3)
- CD44 (3)
- ERBB2 (3)
- ITGA5 (3)
- TNF (3)
- TYRP1 (3)
- ACKR1 (2)
- AGER (2)
- AKT1 (2)
- C3AR1 (2)
- C5AR1 (2)
- CD163 (2)
- CD1A (2)
- CD40 (2)
- CD74 (2)
- CD80 (2)
- CD81 (2)
- CMKLR1 (2)
- CTLA4 (2)
- EPCAM (2)
- EPHA2 (2)
- FAS (2)
- FCAR (2)
- G1 (2)
- GROUP ANTIGEN (2)
- IFNG (2)
- IGM (2)
- IL16 (2)
- IL4 (2)
- IL7R (2)
- ITGB2 (2)
- LTA (2)
- MSLN (2)
- PDCD1 (2)
- PVR (2)
- SIRPG (2)
- TF (2)
- TIGIT (2)
- TNFRSF10B (2)
- TNFRSF9 (2)
- TNFSF18 (2)
- TRAC (2)
- VSIR (2)
- ALPHA-GAL EPITOPE (1)
- ATG13 (1)
- BRD4 (1)
- FOXP1 (1)
- FOXP2 (1)
- FOXP4 (1)
- ITGAM (1)
- L3MBTL1 (1)
- RTN4RL1 (1)
- RTN4RL2 (1)
- SETD7 (1)
- TNFSF13B (1)
- WDR5 (1)
Reactivities
Antibody Hosts
Isotypes
Clonalities
Conjugates
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (20)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (8)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human Fab format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (6)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (5)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (5)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (3)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. (2)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgM format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric murine antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG2 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This full-length, reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric mouse antibody, based on the original rat IgG2b format, created for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original mouse scFv format for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)